These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8396408)

  • 61. Commentary on "Active immunization against poliomyelitis".
    Katz SL
    J Urban Health; 1998 Sep; 75(3):600. PubMed ID: 9762652
    [No Abstract]   [Full Text] [Related]  

  • 62. [Suggestion on the immunization period of Salk vaccine].
    BALESTRINI AM
    Dia Med; 1955 Jun; 27(42):1283. PubMed ID: 13241271
    [No Abstract]   [Full Text] [Related]  

  • 63. Laboratory containment of wild poliovirus.
    Kelly H; Prasopa-Plaizier N; Ballard S
    JAMA; 2001 Aug; 286(5):536. PubMed ID: 11476654
    [No Abstract]   [Full Text] [Related]  

  • 64. Evolution of poliovirus since introduction of attenuated vaccine.
    Grist NR
    Br Med J; 1977 Sep; 2(6088):702. PubMed ID: 198059
    [No Abstract]   [Full Text] [Related]  

  • 65. Expanded programme on immunization. Poliomyelitis in 1988, 1989, and 1990.
    Wkly Epidemiol Rec; 1992 Apr; 67(16):113-7. PubMed ID: 1571237
    [No Abstract]   [Full Text] [Related]  

  • 66. A piece of my mind. Brad missed the miracle.
    Gilsdorf JR
    JAMA; 1995 Aug; 274(6):443. PubMed ID: 7629936
    [No Abstract]   [Full Text] [Related]  

  • 67. Poliovirus type 1 isolated from a budgerigar.
    SOMMERVILLE RG; MONRO IC; CUTHBERT CC
    Lancet; 1958 Mar; 1(7019):512. PubMed ID: 13515269
    [No Abstract]   [Full Text] [Related]  

  • 68. Choice of cell substrate for biological products.
    Beale AJ
    Adv Exp Med Biol; 1979; 118():83-97. PubMed ID: 227238
    [No Abstract]   [Full Text] [Related]  

  • 69. Will containment of wild poliovirus in laboratories and inactivated poliovirus vaccine production sites be effective for global certification?
    Dowdle WR; Wolff C; Sanders R; Lambert S; Best M
    Bull World Health Organ; 2004 Jan; 82(1):59-62. PubMed ID: 15106302
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A developing country perspective on vaccine-associated paralytic poliomyelitis.
    John TJ
    Bull World Health Organ; 2004 Jan; 82(1):53-7; discussion 57-8. PubMed ID: 15106301
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Paralytic poliomyelitis in children with or without immunization against poliomyelitis.
    Nakao T; Chiba S; Horino K; Chiba Y
    Tohoku J Exp Med; 1971 Oct; 105(2):123-7. PubMed ID: 4334612
    [No Abstract]   [Full Text] [Related]  

  • 72. Change from oral poliovirus vaccine to inactivated poliovirus vaccine.
    Mele A; Jefferson T; Franco E; Salmaso S
    Lancet; 2002 Oct; 360(9340):1178. PubMed ID: 12387987
    [No Abstract]   [Full Text] [Related]  

  • 73. Expanded programme on immunization. Wild poliovirus isolated in Alberta, 1993.
    Wkly Epidemiol Rec; 1993 Aug; 68(32):235-6. PubMed ID: 8396408
    [No Abstract]   [Full Text] [Related]  

  • 74. [End phase challenges of poliomyelitis eradication programme realization].
    Jarzabek Z
    Przegl Epidemiol; 2005; 59(1):59-68. PubMed ID: 16013411
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.